Skip to content

Clinical trials

Primary Myelofibrosis trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Phase: Not applicable Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20034
20043
20052
20063
20072
20081
20092
20103
20121
20152
20161
20181
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated9
Unknown status2
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center5
Masonic Cancer Center, University of Minnesota3
Wake Forest University Health Sciences3
City of Hope Medical Center2
OHSU Knight Cancer Institute2
Roswell Park Cancer Institute2
University of California, San Francisco2
University of Rochester2
Barbara Ann Karmanos Cancer Institute1
Brigham and Women's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis38
Precursor Cell Lymphoblastic Leukemia-Lymphoma33
Leukemia, Myeloid, Acute31
Multiple Myeloma31
Myeloproliferative Disorders31
Leukemia, Lymphocytic, Chronic, B-Cell30
Hodgkin Disease29
Lymphoma, Non-Hodgkin29
Lymphoma, Mantle-Cell28
Lymphoma, Large B-Cell, Diffuse27

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.